Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saccharomyces cerevisiae and Reduced Inflammation

Research synthesisLow evidenceModerate effect6 studies · 6 beneficial · 0 neutral · 0 harmful

Across 6 studies, all reported beneficial effects of Saccharomyces cerevisiae on reducing inflammation, with effect sizes ranging from small to large and a predominant moderate effect. Statistically significant findings were observed in 3 studies, including a small RCT (n=12) showing reduced microvascular inflammation and subjective irritation scores. Most evidence comes from in vitro or animal models, limiting direct applicability to humans.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). The evidence base is small (only 6 studies) — conclusions should be considered preliminary. Only one RCT in humans (n=12) was identified; the remainder are in vitro or animal studies, which limits generalizability to human populations. Doses and forms were not consistently reported across studies.

Generated May 12, 2026
7 of 7 papers
Back to top